Schedules of Controlled Substances: Placement of Methoxetamine (MXE) in Schedule I
scheduling · Proposed Rule · Notice of proposed rulemaking. · Published 2021-12-07 · 86 FR 69187
Document
Document number
2021-26293
Federal Register citation
86 FR 69187
Type
Proposed Rule
Action
Notice of proposed rulemaking.
Category
scheduling
Publication date
2021-12-07
Abstract
The Drug Enforcement Administration proposes placing 2- (ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. This action is being taken to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle, methoxetamine.